Total Payments
$143,646
2024 Payments
$292.81
Companies
32
Transactions
337
Medicare Patients
9,574
Medicare Billing
$1.3M
Payment Breakdown by Category
Other$120,500 (83.9%)
Travel$15,186 (10.6%)
Food & Beverage$7,960 (5.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $120,500 | 59 | 83.9% |
| Travel and Lodging | $15,186 | 37 | 10.6% |
| Food and Beverage | $7,960 | 241 | 5.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Depomed, Inc. | $96,707 | 112 | $0 (2017) |
| ASSERTIO THERAPEUTICS, Inc. | $40,739 | 65 | $0 (2019) |
| Vertiflex, Inc. | $2,071 | 10 | $0 (2019) |
| Nevro Corp. | $1,207 | 36 | $0 (2024) |
| Collegium Pharmaceutical, Inc. | $425.76 | 31 | $0 (2022) |
| Medtronic, Inc. | $253.95 | 3 | $0 (2023) |
| Abbott Laboratories | $229.98 | 4 | $0 (2021) |
| BOSTON SCIENTIFIC CORPORATION | $217.67 | 7 | $0 (2022) |
| Medtronic USA, Inc. | $212.51 | 3 | $0 (2017) |
| Stimwave Technologies Incorporated | $163.21 | 2 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $292.81 | 10 | Nevro Corp. ($114.92) |
| 2023 | $448.54 | 11 | Medtronic, Inc. ($230.49) |
| 2022 | $406.40 | 12 | BOSTON SCIENTIFIC CORPORATION ($136.10) |
| 2021 | $546.90 | 27 | Nevro Corp. ($157.65) |
| 2020 | $440.59 | 13 | Abbott Laboratories ($198.59) |
| 2019 | $2,510 | 39 | Vertiflex, Inc. ($2,071) |
| 2018 | $41,288 | 83 | Assertio Therapeutics, Inc. ($40,678) |
| 2017 | $97,712 | 142 | Depomed, Inc. ($96,707) |
All Payment Transactions
337 individual payment records from CMS Open Payments — Page 3 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/02/2021 | Almatica Pharma LLC | NAPRELAN (Drug), GRALISE | Food and Beverage | In-kind items and services | $22.54 | General |
| Category: ANALGESIC | ||||||
| 05/25/2021 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $13.21 | General |
| Category: Opioid Analgesic | ||||||
| 04/29/2021 | Nevro Corp. | Omnia (Device) | Food and Beverage | In-kind items and services | $23.47 | General |
| Category: Spinal Cord Stimulator | ||||||
| 03/09/2021 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $12.77 | General |
| Category: Opioid Analgesic | ||||||
| 03/03/2021 | Nevro Corp. | Omnia (Device) | Food and Beverage | In-kind items and services | $13.22 | General |
| Category: Spinal Cord Stimulator | ||||||
| 03/02/2021 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $0.95 | General |
| Category: Opioid Analgesic | ||||||
| 03/01/2021 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $18.68 | General |
| Category: Opioid Analgesic | ||||||
| 02/09/2021 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $15.53 | General |
| Category: Opioid Analgesic | ||||||
| 02/04/2021 | Nevro Corp. | Omnia (Device) | Food and Beverage | In-kind items and services | $19.75 | General |
| Category: Spinal Cord Stimulator | ||||||
| 01/05/2021 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $9.33 | General |
| Category: Opioid Analgesic | ||||||
| 11/20/2020 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $20.33 | General |
| Category: Opioid Analgesic | ||||||
| 10/13/2020 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $12.36 | General |
| Category: Opioid Analgesic | ||||||
| 09/15/2020 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $14.59 | General |
| Category: Opioid Analgesic | ||||||
| 08/18/2020 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $12.36 | General |
| Category: Opioid Analgesic | ||||||
| 07/16/2020 | Nevro Corp. | Senza Spinal Cord Stimulation System (Device) | Food and Beverage | In-kind items and services | $18.88 | General |
| Category: Spinal Cord Stimulator | ||||||
| 05/28/2020 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $18.64 | General |
| Category: Opioid Analgesic | ||||||
| 03/06/2020 | Abbott Laboratories | Proclaim Family of SCS IPGs (Device) | Food and Beverage | In-kind items and services | $100.00 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 02/24/2020 | Abbott Laboratories | Proclaim Family of SCS IPGs (Device) | Food and Beverage | In-kind items and services | $98.59 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 02/13/2020 | Nevro Corp. | Senza Spinal Cord Stimulation System (Device) | Food and Beverage | In-kind items and services | $90.65 | General |
| Category: Spinal Cord Stimulator | ||||||
| 01/30/2020 | Horizon Therapeutics plc | DUEXIS (Drug) | Food and Beverage | In-kind items and services | $13.15 | General |
| Category: DUEXIS | ||||||
| 01/21/2020 | Stimwave Technologies Incorporated | CFNS StimQ Peripheral Nerve StimulatorSystem (Device), SCS FreedonSpinal Cord Stimulator | Food and Beverage | Cash or cash equivalent | $17.20 | General |
| Category: Neurostimulation | ||||||
| 01/07/2020 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $11.01 | General |
| Category: Opioid Analgesic | ||||||
| 01/02/2020 | Horizon Therapeutics plc | DUEXIS (Drug) | Food and Beverage | In-kind items and services | $12.83 | General |
| Category: DUEXIS | ||||||
| 12/19/2019 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $11.64 | General |
| Category: Opioid Analgesic | ||||||
| 12/04/2019 | Vertiflex, Inc. | Superion ISS (Device) | Travel and Lodging | In-kind items and services | $527.88 | General |
| Category: Spinal stenosis | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 28 | 2,196 | 5,051 | $1.4M | $268,018 |
| 2022 | 29 | 2,575 | 5,603 | $1.7M | $351,766 |
| 2021 | 29 | 2,537 | 5,991 | $1.7M | $376,168 |
| 2020 | 30 | 2,266 | 5,352 | $1.6M | $316,562 |
Total Patients
9,574
Total Services
21,997
Medicare Billing
$1.3M
Procedure Codes
120
All Medicare Procedures & Services
120 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 560 | 1,847 | $415,575 | $175,257 | 42.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 136 | 136 | $47,600 | $17,779 | 37.4% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Facility | 2023 | 83 | 125 | $154,110 | $12,993 | 8.4% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Facility | 2023 | 29 | 41 | $69,225 | $6,350 | 9.2% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Facility | 2023 | 45 | 60 | $101,320 | $6,269 | 6.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 75 | 86 | $15,050 | $6,088 | 40.4% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2023 | 366 | 1,254 | $16,816 | $4,782 | 28.4% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Facility | 2023 | 44 | 54 | $62,910 | $3,141 | 5.0% |
| 96136 | Administration of psychological or neuropsychological test, first 30 minutes | Office | 2023 | 122 | 135 | $13,500 | $3,079 | 22.8% |
| 20553 | Injection of trigger points, 3 or more muscles | Office | 2023 | 32 | 64 | $24,640 | $3,075 | 12.5% |
| 62321 | Injection of substance into middle or upper spine canal using imaging guidance | Facility | 2023 | 29 | 35 | $48,125 | $3,065 | 6.4% |
| 64484 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | Facility | 2023 | 41 | 59 | $42,065 | $2,930 | 7.0% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Facility | 2023 | 36 | 48 | $49,500 | $2,878 | 5.8% |
| 96130 | Evaluation of psychological test, first hour | Office | 2023 | 25 | 26 | $6,110 | $2,565 | 42.0% |
| 64636 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | Facility | 2023 | 27 | 51 | $43,935 | $2,533 | 5.8% |
| 76942 | Ultrasonic guidance for needle placement | Office | 2023 | 27 | 53 | $20,140 | $2,510 | 12.5% |
| 72100 | X-ray of lower and sacral spine, 2-3 views | Facility | 2023 | 153 | 251 | $69,025 | $2,168 | 3.1% |
| 64640 | Destruction of peripheral nerve or branch | Facility | 2023 | 30 | 42 | $47,050 | $2,132 | 4.5% |
| 20611 | Aspiration and/or injection of fluid large joint using ultrasound guidance | Office | 2023 | 18 | 25 | $11,675 | $2,051 | 17.6% |
| 27096 | Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | Facility | 2023 | 23 | 26 | $23,900 | $1,851 | 7.7% |
| 64450 | Injection of anesthetic agent and/or steroid into other nerve or branch | Facility | 2023 | 32 | 44 | $30,300 | $1,085 | 3.6% |
| 96138 | Administration of psychological or neuropsychological test by technician, first 30 minutes | Office | 2023 | 33 | 34 | $2,618 | $878.14 | 33.5% |
| 77002 | Fluoroscopic guidance for needle placement | Facility | 2023 | 14 | 15 | $3,500 | $854.14 | 24.4% |
| 20610 | Aspiration and/or injection of fluid from large joint | Facility | 2023 | 19 | 21 | $7,875 | $671.25 | 8.5% |
| 72040 | X-ray of upper spine, 2-3 views | Facility | 2023 | 40 | 63 | $17,325 | $551.39 | 3.2% |
About Dr. Robert Sickler, MD
Dr. Robert Sickler, MD is a Pain Medicine healthcare provider based in Houston, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1952338279.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Sickler, MD has received a total of $143,646 in payments from pharmaceutical and medical device companies, with $292.81 received in 2024. These payments were reported across 337 transactions from 32 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($120,500).
As a Medicare-enrolled provider, Sickler has provided services to 9,574 Medicare beneficiaries, totaling 21,997 services with total Medicare billing of $1.3M. Data is available for 4 years (2020–2023), covering 120 distinct procedure/service records.
Ad
Practice Information
- Specialty Pain Medicine
- Other Specialties Pain Medicine
- Location Houston, TX
- Active Since 06/26/2006
- Last Updated 07/09/2025
- Taxonomy Code 2081P2900X
- Entity Type Individual
- NPI Number 1952338279
Products in Payments
- Nucynta (Drug) $76,013
- Gralise (Drug) $61,348
- Superion ISS (Device) $2,071
- Senza Spinal Cord Stimulation System (Device) $697.37
- XTAMPZA (Drug) $398.72
- Senza (Device) $257.43
- Omnia (Device) $252.44
- Proclaim Family of SCS IPGs (Device) $216.69
- MYSTIM (Device) $152.25
- Algovita (Device) $145.27
- INTELLIS ADAPTIVESTIM (Device) $125.72
- PERCEPT PC BRAINSENSE (Device) $104.77
- ZOHYDRO ER (Drug) $104.27
- Superion Indirect Decompression System (Device) $103.78
- LYRICA (Drug) $83.98
- BELBUCA (Drug) $83.33
- DUEXIS (Drug) $82.74
- ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH (Drug) $82.70
- Cambia (Drug) $79.98
- PAINTEQ (Device) $77.24
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pain Medicine Doctors in Houston
Michael Sprintz, Do, DO
Pain Medicine — Payments: $65,205
Pain Medicine $65,205
Dr. James Lai, M.d, M.D
Pain Medicine — Payments: $55,896
Pain Medicine $55,896
Dr. Mayur Kanjia, M.d, M.D
Pain Medicine — Payments: $50,110
Pain Medicine $50,110
Wai-Kwan Yung, M.d, M.D
Pain Medicine — Payments: $40,975
Pain Medicine $40,975
Mitchell Engle, M.d., Ph.d, M.D., PH.D
Pain Medicine — Payments: $39,934
Pain Medicine $39,934
Dr. Thuan Dao, Md, MD
Pain Medicine — Payments: $25,655
Pain Medicine $25,655